PDCD1 and neoplasm: A recent study conducted by Sanchez-Paulete and colleagues on a mouse orthotopic lung tumor model, showed that targeting the macrophage marker (F4/80) with F4-CAR-T cells delayed solid tumor progression, thereby enhancing anti-tumor immunity comparably to PD-1 blockade and prolonged animal survival [153].